Skip to main content
Article
Dynamics of tumor response in advanced melanoma patients treated with Coxsackievirus A21.
Journal of Clinical Oncology (2016)
  • Robert Hans Ingemar Andtbacka, Huntsman Cancer Institute
  • Brendan D. Curti, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR;
  • Howard Kaufman, Rush University Medical Center
  • John J. Nemunaitis, Mary Crowley Cancer Research Centers, Dallas, TX;
  • Gregory A. Daniels, University of California, San Diego
  • Sigrun Hallmeyer, Oncology Specialists SC, Park Ridge, IL;
  • Eric D. Whitman, Atlantic Melanoma Ctr, Morristown, NJ;
  • Jose Lutzky, Mount Sinai Hospital
  • Stephen Michael Schultz, American Health Network Indiana, Indianapolis, IN;
  • Lynn E. Spitler, St. Mary's Medical Center, Tiburon, CA;
  • Zipei Feng, Oregon Health & Science University
  • Christopher Paustian, Earle A. Chiles Research Institute, Portalnd, OR;
  • Bernard A. Fox, Providence Portland Medical Center
  • Carlo Bruno Bifulco, Providence Portland Medical Center
  • Karl Zhou, inVentiv Health Clinical, Bridgewater, NJ;
  • Mark Grose, Viralytics, Ltd., Sydney, Australia;
  • Darren Shafren, Viralytics, Ltd., Sydney, Australia;
Publication Date
May 20, 2016
DOI
10.1200/JCO.2016.34.15_SUPPL.9553
Citation Information
Robert Hans Ingemar Andtbacka, Brendan D. Curti, Howard Kaufman, John J. Nemunaitis, et al.. "Dynamics of tumor response in advanced melanoma patients treated with Coxsackievirus A21." Journal of Clinical Oncology Vol. 34 (2016) p. 9553 - 9553
Available at: http://works.bepress.com/carlo-bifulco/90/